🚀 From Google Podcasts to Moon FM in No Time: Your Hassle-Free Migration Guide
👉

Hematologic Oncology Update

Dr. Neil Love

This series bridges the gap between research and patient care by providing medical oncologists with access to important information on relevant advances in the treatment of hematologic malignancies.

  • 51 minutes 43 seconds
    Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis
    Dr Stephen T Oh shares his perspectives on the evolving therapeutic landscape for patients with myelofibrosis.
    17 December 2024, 7:18 pm
  • 51 minutes 44 seconds
    Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes
    Dr Harry Paul Erba shares his perspectives on the evolving therapeutic landscape for patients with leukemia and myelodysplastic syndromes.
    13 December 2024, 8:10 pm
  • 1 hour 46 minutes
    Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria
    Dr Gloria Gerber, Dr Jamie Koprivnikar, Prof Alexander Röth and Dr Jamile Shammo discuss available and emerging research, patient cases from participating junior clinical investigator faculty and senior clinical investigator faculty perspectives of relevant research data informing clinical decision-making for paroxysmal nocturnal hemoglobinuria.
    4 December 2024, 5:23 pm
  • 52 minutes 45 seconds
    Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma
    Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with multiple myeloma.
    26 November 2024, 8:29 pm
  • 58 minutes 36 seconds
    Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
    Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia.
    23 November 2024, 1:01 am
  • 56 minutes 11 seconds
    Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    20 November 2024, 8:36 pm
  • 56 minutes 14 seconds
    What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
    Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma.
    8 November 2024, 8:46 pm
  • 57 minutes 58 seconds
    Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
    Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Michael Wang from the University of Texas MD Anderson Cancer Center in Houston discuss the current role of Bruton tyrosine kinase inhibitors for the management of newly diagnosed and relapsed/refractory mantle cell lymphoma.
    30 October 2024, 7:27 pm
  • 1 hour 49 minutes
    Practical Perspectives: Current Management of Chronic Myeloid Leukemia
    Drs Bhavana (Tina) Bhatnagar, Amanda Blackmon, Jorge Cortes, Michael J Mauro and Neil P Shah discuss recent updates on clinical treatment strategies for chronic myeloid leukemia.
    24 October 2024, 7:58 pm
  • 46 minutes 32 seconds
    Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma
    Dr Stephen Horwitz from Memorial Sloan Kettering Cancer Center in New York, New York, discusses management strategies for previously untreated and relapsed peripheral T-cell lymphomas.
    17 October 2024, 7:12 pm
  • 58 minutes 58 seconds
    Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
    Dr Matthew S Davids from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews current available data and ongoing investigational treatment approaches for chronic lymphocytic leukemia.
    10 October 2024, 6:40 pm
  • More Episodes? Get the App
About Hematologic Oncology Update
Links
Listeners Also Subscribed To
© MoonFM 2024. All rights reserved.